EGFR and colorectal carcinoma: Combinations of RMC-9805 with either RMC-6236 (RASMULTI(ON) inhibitor) or an anti-EGFR antibody improved the depth of the response and delayed the onset of resistance in KRAS G12D CRC models [84].